Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 4 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation.
Cancer Lett. 2011 Dec 8;311(2):219-29. doi: 10.1016/j.canlet.2011.07.023. Epub 2011 Aug 6.
Cancer Lett. 2011.
PMID: 21872389
Free PMC article.
MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.
Seshadri M, Ciesielski MJ.
Seshadri M, et al.
J Cereb Blood Flow Metab. 2009 Aug;29(8):1373-82. doi: 10.1038/jcbfm.2009.68. Epub 2009 May 20.
J Cereb Blood Flow Metab. 2009.
PMID: 19458603
Free PMC article.
Item in Clipboard
Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts.
Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M.
Cao S, et al.
Oral Oncol. 2011 Jun;47(6):459-66. doi: 10.1016/j.oraloncology.2011.04.001. Epub 2011 May 6.
Oral Oncol. 2011.
PMID: 21530364
Free PMC article.
Item in Clipboard
Isolation and applications of prostate side population cells based on dye cycle violet efflux.
Gangavarpu KJ, Huss WJ.
Gangavarpu KJ, et al.
Curr Protoc Toxicol. 2011 Feb;Chapter 22:Unit 22.2. doi: 10.1002/0471140856.tx2202s47.
Curr Protoc Toxicol. 2011.
PMID: 21400686
Free PMC article.
Item in Clipboard
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G; Australian Ovarian Cancer Study Group; Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, Ness RB, Goode EL, Cunningham JM, Fridley BL, Vierkant RA, Tworoger SS, Whittemore AS, McGuire V, Sieh W, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Rossing MA, Doherty JA, Goodman MT, Carney ME, Lurie G, Wilkens LR, Kjær SK, Høgdall E, Cramer DW, Terry KL, Garcia-Closas M, Yang H, Lissowska J, Anton-Culver H, Ziogas A, Schildkraut JM, Berchuck A, Pharoah PD; Ovarian Cancer Association Consortium.
Amankwah EK, et al.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1028-31. doi: 10.1158/1055-9965.EPI-11-0053. Epub 2011 Mar 17.
Cancer Epidemiol Biomarkers Prev. 2011.
PMID: 21415361
Free PMC article.
Item in Clipboard
The 1-carbamoyl-2-oxo-4,5-dihydroxyimidazolidine component of ROS-induced DNA damage in white blood cells.
Iijima H, Patrzyc HB, Budzinski EE, Dawidzik JB, Freund HG, Box HC.
Iijima H, et al.
Radiat Res. 2010 Jul;174(1):101-6. doi: 10.1667/RR2087.1.
Radiat Res. 2010.
PMID: 20681804
Free PMC article.
Item in Clipboard
Cite
Cite